Additive inhibition of lordosis by simultaneous treatments with GABAA and GABAB receptor agonists, muscimol and baclofen, in female rats

Shizuko Wada, Shunji Yamada, Korehito Yamanouchi

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    In order to investigate the relationship between GABAA and GABAB receptors in the induction of lordosis behavior, agonists of these receptor subtypes were injected simultaneously to estrogen-treated ovariectomized rats and lordosis behavior was observed before and after the injections. The GABAA receptor agonist, muscimol (MUS), at a dose in the range from 1.0 to 1.4 mg/kg body weight (bw) or the GABAB receptor agonist, baclofen (BAC) at a dose in the range from 1 to 10 mg/kg bw, was injected intraperitoneally. The lordosis quotient (LQ) decreased after treatments with MUS or BAC and a dose-dependent decrease of LQ was observed in MUS or BAC-treated rats. When 1.2 mg/kg bw MUS and 5 mg/kg bw BAC were injected simultaneously, the mean LQ decreased strongly and was significantly lower than the values obtained after single injections of the agonists at these doses (P < 0.05). In addition, to ascertain the time-course of changes, a behavioral test was carried out 7 times from 15 to 180 min after the injection of agonists. The low LQ in the rats injected with both MUS and BAC continued longer than in rats given single injections. These results indicate that both GABAA and GABAB receptors are involved in lordosis-inhibiting mechanisms by the GABA neuron and operate independently.

    Original languageEnglish
    Pages (from-to)590-593
    Number of pages4
    JournalPharmacology Biochemistry and Behavior
    Volume90
    Issue number4
    DOIs
    Publication statusPublished - 2008 Oct

    Fingerprint

    GABA-A Receptor Agonists
    Lordosis
    Muscimol
    Baclofen
    Rats
    GABA-A Receptors
    Body Weight
    Injections
    Therapeutics
    GABA-B Receptors
    gamma-Aminobutyric Acid
    GABAergic Neurons
    Neurons
    Estrogens
    Inhibition (Psychology)

    Keywords

    • Baclofen
    • Female rat
    • GABA receptor
    • GABA receptor
    • Lordosis
    • Muscimol

    ASJC Scopus subject areas

    • Biochemistry
    • Behavioral Neuroscience
    • Pharmacology

    Cite this

    Additive inhibition of lordosis by simultaneous treatments with GABAA and GABAB receptor agonists, muscimol and baclofen, in female rats. / Wada, Shizuko; Yamada, Shunji; Yamanouchi, Korehito.

    In: Pharmacology Biochemistry and Behavior, Vol. 90, No. 4, 10.2008, p. 590-593.

    Research output: Contribution to journalArticle

    @article{a7e0f4a4769143d7a0aaf1be6f5ef5fd,
    title = "Additive inhibition of lordosis by simultaneous treatments with GABAA and GABAB receptor agonists, muscimol and baclofen, in female rats",
    abstract = "In order to investigate the relationship between GABAA and GABAB receptors in the induction of lordosis behavior, agonists of these receptor subtypes were injected simultaneously to estrogen-treated ovariectomized rats and lordosis behavior was observed before and after the injections. The GABAA receptor agonist, muscimol (MUS), at a dose in the range from 1.0 to 1.4 mg/kg body weight (bw) or the GABAB receptor agonist, baclofen (BAC) at a dose in the range from 1 to 10 mg/kg bw, was injected intraperitoneally. The lordosis quotient (LQ) decreased after treatments with MUS or BAC and a dose-dependent decrease of LQ was observed in MUS or BAC-treated rats. When 1.2 mg/kg bw MUS and 5 mg/kg bw BAC were injected simultaneously, the mean LQ decreased strongly and was significantly lower than the values obtained after single injections of the agonists at these doses (P < 0.05). In addition, to ascertain the time-course of changes, a behavioral test was carried out 7 times from 15 to 180 min after the injection of agonists. The low LQ in the rats injected with both MUS and BAC continued longer than in rats given single injections. These results indicate that both GABAA and GABAB receptors are involved in lordosis-inhibiting mechanisms by the GABA neuron and operate independently.",
    keywords = "Baclofen, Female rat, GABA receptor, GABA receptor, Lordosis, Muscimol",
    author = "Shizuko Wada and Shunji Yamada and Korehito Yamanouchi",
    year = "2008",
    month = "10",
    doi = "10.1016/j.pbb.2008.04.020",
    language = "English",
    volume = "90",
    pages = "590--593",
    journal = "Pharmacology Biochemistry and Behavior",
    issn = "0091-3057",
    publisher = "Elsevier Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - Additive inhibition of lordosis by simultaneous treatments with GABAA and GABAB receptor agonists, muscimol and baclofen, in female rats

    AU - Wada, Shizuko

    AU - Yamada, Shunji

    AU - Yamanouchi, Korehito

    PY - 2008/10

    Y1 - 2008/10

    N2 - In order to investigate the relationship between GABAA and GABAB receptors in the induction of lordosis behavior, agonists of these receptor subtypes were injected simultaneously to estrogen-treated ovariectomized rats and lordosis behavior was observed before and after the injections. The GABAA receptor agonist, muscimol (MUS), at a dose in the range from 1.0 to 1.4 mg/kg body weight (bw) or the GABAB receptor agonist, baclofen (BAC) at a dose in the range from 1 to 10 mg/kg bw, was injected intraperitoneally. The lordosis quotient (LQ) decreased after treatments with MUS or BAC and a dose-dependent decrease of LQ was observed in MUS or BAC-treated rats. When 1.2 mg/kg bw MUS and 5 mg/kg bw BAC were injected simultaneously, the mean LQ decreased strongly and was significantly lower than the values obtained after single injections of the agonists at these doses (P < 0.05). In addition, to ascertain the time-course of changes, a behavioral test was carried out 7 times from 15 to 180 min after the injection of agonists. The low LQ in the rats injected with both MUS and BAC continued longer than in rats given single injections. These results indicate that both GABAA and GABAB receptors are involved in lordosis-inhibiting mechanisms by the GABA neuron and operate independently.

    AB - In order to investigate the relationship between GABAA and GABAB receptors in the induction of lordosis behavior, agonists of these receptor subtypes were injected simultaneously to estrogen-treated ovariectomized rats and lordosis behavior was observed before and after the injections. The GABAA receptor agonist, muscimol (MUS), at a dose in the range from 1.0 to 1.4 mg/kg body weight (bw) or the GABAB receptor agonist, baclofen (BAC) at a dose in the range from 1 to 10 mg/kg bw, was injected intraperitoneally. The lordosis quotient (LQ) decreased after treatments with MUS or BAC and a dose-dependent decrease of LQ was observed in MUS or BAC-treated rats. When 1.2 mg/kg bw MUS and 5 mg/kg bw BAC were injected simultaneously, the mean LQ decreased strongly and was significantly lower than the values obtained after single injections of the agonists at these doses (P < 0.05). In addition, to ascertain the time-course of changes, a behavioral test was carried out 7 times from 15 to 180 min after the injection of agonists. The low LQ in the rats injected with both MUS and BAC continued longer than in rats given single injections. These results indicate that both GABAA and GABAB receptors are involved in lordosis-inhibiting mechanisms by the GABA neuron and operate independently.

    KW - Baclofen

    KW - Female rat

    KW - GABA receptor

    KW - GABA receptor

    KW - Lordosis

    KW - Muscimol

    UR - http://www.scopus.com/inward/record.url?scp=48749105020&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=48749105020&partnerID=8YFLogxK

    U2 - 10.1016/j.pbb.2008.04.020

    DO - 10.1016/j.pbb.2008.04.020

    M3 - Article

    VL - 90

    SP - 590

    EP - 593

    JO - Pharmacology Biochemistry and Behavior

    JF - Pharmacology Biochemistry and Behavior

    SN - 0091-3057

    IS - 4

    ER -